23andMe’s future prompts more worries, as genomic data analysis improves
Customers of genetic data outfit 23andMe may be at greater risk than they realize, suggests a New York Times story that argues the company’s woes could be short-lived compared to the longer-term threats facing those roughly 15 million people if...